The importance of RALB and TBK1 to RAS-induced lung cancer was confirmed in a RNA inhibitor screen of synthetic lethal partners of oncogenic KRAS, where RALB and TBK1 were identified as top targets (132). The gene discussed is KRAS; the disease is lung cancer.